Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
35.19%
Operating Margin
9.90%
Net Margin
35.00%
Efficiency Metrics
Revenue per Expense Ratio
1.11
R&D as % of Revenue
1.23%
Earnings Quality
EBITDA Margin
16.19%
Income Tax Rate
15.35%
EPS
18.2100000000
Balance Sheet Analysis
Current Ratio
2.27
Cash Ratio
1.00
Working Capital
$615.80M
Debt to Equity
0.43
Debt to Assets
23.85%
Equity Ratio
54.93%
Cash Flow Analysis
Operating Cash Flow Ratio
4.46%
Free Cash Flow Ratio
1.15%
CapEx to Revenue
3.31%
Dividends Paid
$12.80M
Stock Buybacks
$5.10M
Total Shareholder Returns
$17.90M
Cash Position Change
561.15%
Key Takeaways (2023 FY)
Revenue declined by 23.157894736842%, indicating potential market challenges
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
-23.16%
Net Income
324.02%
EPS
324.48%
Operating Income
-2.20%
Operational Efficiency
R&D Expenses
-30.27%
SG&A Expenses
-8.51%
Operating Cash Flow
-47.86%
Free Cash Flow
-65.08%
Balance Sheet Health
Assets
4.89%
Debt
-33.90%
Book Value per Share
72.59%
Inventory
-25.92%
Shareholder Returns
Dividends per Share
-2.29%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
-3.67%
5Y Revenue/Share
-13.57%
3Y Dividend/Share
0.00%
5Y Dividend/Share
-2.60%